Primary presentation and clinical course of pediatric and adolescent patients with differentiated thyroid carcinoma after radioiodine therapy.

adolescents children patient outcome pediatric oncology radioiodine therapy thyroid carcinoma

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2023
Historique:
received: 09 06 2023
accepted: 05 09 2023
medline: 18 10 2023
pubmed: 18 10 2023
entrez: 18 10 2023
Statut: epublish

Résumé

Differentiated thyroid carcinoma (DTC) in childhood and during adolescence is extremely rare. Pediatric DTC commonly presents with advanced disease at diagnosis including a high prevalence of cervical lymph node metastases and pulmonary metastases. Studies in children with DTC are limited. Therefore, we aimed to evaluate the initial presentation, effectiveness of radioiodine therapy (RIT), and long-term outcome of prepubertal in comparison to pubertal/postpubertal patients. Eighty-five pediatric and young patients aged 6.4 to 21.9 years with histopathologically confirmed DTC were retrospectively included. They all underwent total thyroidectomy followed by RIT. Initial presentation and outcome of prepubertal and pubertal/postpubertal patients were compared 1 year after RIT, during follow-up, and at the last visit of follow-up. Prepubertal patients presented with significantly higher T and M stages. One year after RIT, 42/81 (52%) patients still presented with evidence of disease (ED). During follow-up of a median of 7.9 years, prepubertal patients were less often in complete remission (58% vs. 82% in pubertal patients). At the last visit of follow-up, 19/80 (24%) patients still had ED without statistical differences between the two groups (42% prepubertal vs. 18% pubertal/postpubertal, Prepubertal children with DTC presented with a more advanced tumor stage at the initial presentation. During follow-up, they present more often with ED. However, at the end of our study, we did not observe statistically relevant differences in patient outcomes between the prepubertal and pubertal/postpubertal groups.

Identifiants

pubmed: 37849815
doi: 10.3389/fonc.2023.1237472
pmc: PMC10577432
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1237472

Informations de copyright

Copyright © 2023 Burgard, Zacherl, Todica, Hornung, Grawe, Pekrul, Zimmermann, Schmid-Tannwald, Ladurner, Krenz, Trupka, Wagner, Bartenstein, Spitzweg and Wenter.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Endocr Rev. 2011 Dec;32(6):798-826
pubmed: 21880704
J Pediatr. 2010 Oct;157(4):648-52
pubmed: 20553841
World J Surg. 2010 Jun;34(6):1192-202
pubmed: 20087589
Thyroid. 2002 Aug;12(8):683-702
pubmed: 12225637
Genes (Basel). 2019 Sep 18;10(9):
pubmed: 31540418
Asian Pac J Cancer Prev. 2014;15(17):7271-5
pubmed: 25227827
J Pediatr. 2009 May;154(5):708-14
pubmed: 19167722
Thyroid. 2005 Apr;15(4):320-5
pubmed: 15876153
World J Surg. 2015 Sep;39(9):2259-65
pubmed: 25802237
Clin Endocrinol (Oxf). 2009 Apr;70(4):629-35
pubmed: 18710471
Thyroid. 2010 Oct;20(10):1095-101
pubmed: 20860418
Cancer. 2019 Jul 15;125(14):2359-2361
pubmed: 31012950
Eur Thyroid J. 2022 Nov 29;11(6):
pubmed: 36228315
Head Neck. 2023 Jan;45(1):85-94
pubmed: 36200593
J Zhejiang Univ Sci B. 2017 May;18(5):430-436
pubmed: 28471115
Thyroid. 2015 Jul;25(7):716-59
pubmed: 25900731
J Clin Endocrinol Metab. 2000 Mar;85(3):1170-5
pubmed: 10720057
Thyroid. 2021 Nov;31(11):1707-1714
pubmed: 34514857
Pediatrics. 2018 Dec;142(6):
pubmed: 30478245
Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1941-59
pubmed: 18670773
J Pediatr Endocrinol Metab. 2006 Dec;19(12):1377-93
pubmed: 17252690
J Pediatr Endocrinol Metab. 2003 Jun;16(5):693-702
pubmed: 12880118
Pediatr Blood Cancer. 2014 Jul;61(7):1168-72
pubmed: 24677749
J Clin Endocrinol Metab. 2022 Jan 1;107(1):e165-e177
pubmed: 34415989
Pediatr Dev Pathol. 2017 Jun;20(3):206-212
pubmed: 28521635
Ann Surg. 2006 Apr;243(4):525-32
pubmed: 16552205
Acta Clin Croat. 2019 Mar;58(1):119-127
pubmed: 31363334
Thyroid. 2017 Dec;27(12):1481-1489
pubmed: 29132262
Int J Pediatr. 2012;2012:125389
pubmed: 22164182
J Clin Endocrinol Metab. 1987 Dec;65(6):1088-94
pubmed: 3680475
JCO Precis Oncol. 2021 Jan 14;1:
pubmed: 34036219
Thorac Cancer. 2018 Nov;9(11):1453-1460
pubmed: 30209893
J Thyroid Res. 2011;2011:845362
pubmed: 21904689
J Endocrinol Invest. 1999 Nov;22(10):781-9
pubmed: 10614528
Thyroid. 2020 Dec;30(12):1771-1780
pubmed: 32495721
Thyroid. 2010 Apr;20(4):375-80
pubmed: 20373982
J Nucl Med. 2014 May;55(5):710-7
pubmed: 24722527
Cancer. 2019 Jul 15;125(14):2497-2505
pubmed: 31012956
CA Cancer J Clin. 2017 Mar;67(2):93-99
pubmed: 28094848
Clin Endocrinol (Oxf). 1998 Nov;49(5):619-28
pubmed: 10197078
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Clinics (Sao Paulo). 2011;66(2):281-6
pubmed: 21484047
Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2526-2535
pubmed: 31410542
Thyroid. 2015 Jun;25(6):681-7
pubmed: 25851829

Auteurs

Caroline Burgard (C)

Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Department of Nuclear Medicine, Saarland University, UdS, Homburg, Germany.

Mathias Johannes Zacherl (MJ)

Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Interdisciplinary Center for Thyroid Carcinoma (ISKUM), LMU University Hospital, LMU Munich, Munich, Germany.

Andrei Todica (A)

Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Interdisciplinary Center for Thyroid Carcinoma (ISKUM), LMU University Hospital, LMU Munich, Munich, Germany.

Julia Hornung (J)

Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.

Freba Grawe (F)

Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.

Isabell Pekrul (I)

Department of Anaesthesiology, LMU University Hospital, LMU Munich, Munich, Germany.

Petra Zimmermann (P)

Interdisciplinary Center for Thyroid Carcinoma (ISKUM), LMU University Hospital, LMU Munich, Munich, Germany.
Department of Visceral and Endocrinological Surgery, LMU University Hospital, LMU Munich, Munich, Germany.

Christine Schmid-Tannwald (C)

Interdisciplinary Center for Thyroid Carcinoma (ISKUM), LMU University Hospital, LMU Munich, Munich, Germany.
Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.

Roland Ladurner (R)

Department of Surgery, Martha-Maria Krankenhaus, Munich, Germany.

Detlef Krenz (D)

Department of Surgery, Klinikum Dritter Orden, Munich, Germany.

Arnold Trupka (A)

Department of Endocrine Surgery, Starnberg Hospital, Starnberg, Germany.

Johanna Wagner (J)

Department of Pediatric Neurology, Developmental Medicine and Social Pediatrics, Dr. von Hauner Children's Hospital, LMU University Hospital, LMU Munich, Munich, Germany.

Peter Bartenstein (P)

Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.

Christine Spitzweg (C)

Interdisciplinary Center for Thyroid Carcinoma (ISKUM), LMU University Hospital, LMU Munich, Munich, Germany.
Department of Internal Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.

Vera Wenter (V)

Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.

Classifications MeSH